Indeed, our findings suggest that DNGR-1-dependent cross-presentation, when not blocked by sGSN, favors cross-priming of anti-tumor CD8+ T cells specific for mutated proteins that are part of the actin cytoskeleton (Figure S7E). This evidence concerns the gene CLEC9A and neoplasm.